Known Side Effects and Risks Relevant to Women's Health Key risks for women include gastrointestinal effects, pancreatitis, gallbladder disease, and potential bone density loss, particularly relevant to perimenopausal and postmenopausal women
While speculative at this stage, the potential for retatrutide to impact aging-related metabolic decline could open entirely new therapeutic applications beyond traditional disease treatment
The Guide is also available for purchase and Government Executive readers can save 20% by entering promo code GOVEXEC at checkout.
Board-certified doctors Clinically backed treatments Medical guidance 100% Personalized 100% Supported Designed around your life From consultation to treatment delivery, Mochi is designed to make care feel more accessible, flexible, and easier to navigate
Drug-specific rebate information is considered proprietary, but national estimates suggest significant rebates for GLP-1 drugs